【摘要】 目的 探讨无痛分娩产妇给予瑞芬太尼静脉自控分娩镇痛对产程及母婴结局的影响。方法 选取2021年9月至2022年3月于福建省泉州市儿童医院进行无痛分娩的120例产妇作为研究对象，按照随机数字表法将其分成观察组和对照组，各60例。对照组采用硬膜外阻滞自控镇痛，观察组采用瑞芬太尼静脉自控分娩镇痛，比较两组产妇的产程及母婴结局。结果 观察组产妇的第一产程、第二产程、第三产程、总产程均短于对照组，差异有统计学意义（P<0.05）。观察组的不良母婴结局总发生率低于对照组，差异有统计学意义（P<0.05）。结论 无痛分娩产妇给予瑞芬太尼静脉自控分娩镇痛，能够缩短产程，降低不良母婴结局发生率。更多还原

【Abstract】 Objective To investigate the effect of intravenous controlled labor analgesia with Remifentanil on labor process and maternal and infant outcomes. Methods A total of 120 cases of parturient who underwent painless labor in Quanzhou Women’s and Children’s Hospital from September 2021 to March 2022 were selected as the research objects. According to the random number table method, they were divided into observation group and control group, with 60 cases in each group.The control group used epidural analgesia, and the observation group used Remifentanil intravenous controlled labor analgesia. The labor process and maternal and infant outcomes were compared between the two groups. Results The first stage of labor process, the second stage of labor process, the third stage of labor process and the total stage of labor process in the observation group were shorter than those in the control group, the differences were statistically significant(P<0.05).The total incidence of adverse maternal and infant outcomes in the observation group was lower than that in the control group, the difference was statistically significant(P <0.05). Conclusion Intravenous controlled labor analgesia with Remifentanil can shorten the labor process and reduce the incidence of adverse maternal and infant outcomes.更多还原